Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT03945188




Registration number
NCT03945188
Ethics application status
Date submitted
8/05/2019
Date registered
10/05/2019
Date last updated
20/12/2022

Titles & IDs
Public title
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Scientific title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
Secondary ID [1] 0 0
2018-003985-15
Secondary ID [2] 0 0
APD334-301
Universal Trial Number (UTN)
Trial acronym
ELEVATE UC 52
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Ulcerative Colitis 0 0
Condition category
Condition code
Oral and Gastrointestinal 0 0 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Inflammatory and Immune System 0 0 0 0
Other inflammatory or immune system disorders
Oral and Gastrointestinal 0 0 0 0
Inflammatory bowel disease

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - Etrasimod
Treatment: Drugs - Placebo

Experimental: Etrasimod 2 mg -

Placebo Comparator: Placebo -


Treatment: Drugs: Etrasimod
Etrasimod 2 mg tablet by mouth, once daily up to 52 weeks of treatment

Treatment: Drugs: Placebo
Etrasimod matching placebo tablet by mouth, once daily up to 52 weeks of treatment
Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Percentage of Participants Achieving Clinical Remission at Week 12
Timepoint [1] 0 0
At Week 12
Primary outcome [2] 0 0
Percentage of Participants Achieving Clinical Remission at Week 52
Timepoint [2] 0 0
At Week 52
Secondary outcome [1] 0 0
Percentage of Participants Achieving Endoscopic Improvement at Week 12
Timepoint [1] 0 0
At Week 12
Secondary outcome [2] 0 0
Percentage of Participants Achieving Endoscopic Improvement at Week 52
Timepoint [2] 0 0
At Week 52
Secondary outcome [3] 0 0
Percentage of Participants Achieving Symptomatic Remission at Week 12
Timepoint [3] 0 0
At Week 12
Secondary outcome [4] 0 0
Percentage of Participants Achieving Symptomatic Remission at Week 52
Timepoint [4] 0 0
At Week 52
Secondary outcome [5] 0 0
Percentage of Participants With Mucosal Healing at Week 12
Timepoint [5] 0 0
At Week 12
Secondary outcome [6] 0 0
Percentage of Participants With Mucosal Healing at Week 52
Timepoint [6] 0 0
At Week 52
Secondary outcome [7] 0 0
Percentage of Participants Achieving Corticosteroid-free Clinical Remission at Week 52
Timepoint [7] 0 0
At Week 52
Secondary outcome [8] 0 0
Percentage of Participants Achieving Sustained Clinical Remission at Both Weeks 12 and 52
Timepoint [8] 0 0
At Weeks 12 and 52
Secondary outcome [9] 0 0
Percentage of Participants Achieving Clinical Response at Week 12
Timepoint [9] 0 0
At Week 12
Secondary outcome [10] 0 0
Percentage of Participants Achieving Clinical Response at Week 52
Timepoint [10] 0 0
At Week 52
Secondary outcome [11] 0 0
Percentage of Participants Achieving Clinical Response at Both Weeks 12 and 52
Timepoint [11] 0 0
At Weeks 12 and 52
Secondary outcome [12] 0 0
Percentage of Participants With Mucosal Healing at Both Weeks 12 and 52
Timepoint [12] 0 0
At Weeks 12 and 52
Secondary outcome [13] 0 0
Percentage of Participants Achieving Endoscopic Normalization at Week 12
Timepoint [13] 0 0
At Week 12
Secondary outcome [14] 0 0
Percentage of Participants Achieving Endoscopic Normalization at Week 52
Timepoint [14] 0 0
At Week 52
Secondary outcome [15] 0 0
Percentage of Participants Achieving Endoscopic Normalization at Both Weeks 12 and 52
Timepoint [15] 0 0
At Weeks 12 and 52
Secondary outcome [16] 0 0
Percentage of Participants Achieving Symptomatic Remission by Study Visit
Timepoint [16] 0 0
At Weeks 2, 4, 8, 16, 20, 24, 32, 40, and 48
Secondary outcome [17] 0 0
Percentage of Participants Achieving Complete Symptomatic Remission by Study Visit
Timepoint [17] 0 0
At Weeks 2, 4, 8, 12, 16, 20, 24, 32, 40, 48 and 52
Secondary outcome [18] 0 0
Percentage of Participants Achieving Non-invasive Clinical Response by Study Visit
Timepoint [18] 0 0
At Weeks 2, 4, 8, 12, 16, 20, 24, 32, 40, 48, and 52
Secondary outcome [19] 0 0
Percentage of Participants Achieving Symptomatic Response by Study Visit
Timepoint [19] 0 0
At Weeks 2, 4, 8, 12, 16, 20, 24, 32, 40, 48, and 52
Secondary outcome [20] 0 0
Percentage of Participants Achieving 4-week Corticosteroid-free Clinical Remission at Week 52 Among Participants Receiving Corticosteroids at Baseline
Timepoint [20] 0 0
At Week 52
Secondary outcome [21] 0 0
Percentage of Participants Achieving Clinical Remission at Week 52 Among Participants in Clinical Response at Week 12
Timepoint [21] 0 0
At Week 52

Eligibility
Key inclusion criteria
Inclusion criteria:

1. Diagnosed with ulcerative colitis (UC) = 3 months prior to screening

2. Active UC confirmed by endoscopy
Minimum age
16 Years
Maximum age
80 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Exclusion criteria:

1. Severe extensive colitis

2. Diagnosis of Crohn's disease (CD) or indeterminate colitis or the presence or history
of a fistula consistent with CD

3. Diagnosis of microscopic colitis, ischemic colitis, or infectious colitis

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
13/06/2019
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
16/02/2022
Sample size
Target
Accrual to date
Final
433
Recruitment in Australia
Recruitment state(s)
NSW,QLD,VIC
Recruitment hospital [1] 0 0
Bankstown-Lidcombe Hospital - Bankstown
Recruitment hospital [2] 0 0
Nepean Hospital - Kingswood
Recruitment hospital [3] 0 0
Coastal Digestive Health Pty Ltd - Maroochydore
Recruitment hospital [4] 0 0
Coral Sea Clinical Research Institute - North Mackay
Recruitment hospital [5] 0 0
Austin Health Gastroenterology Department - Heidelberg
Recruitment hospital [6] 0 0
Royal Melbourne Hospital - Parkville
Recruitment postcode(s) [1] 0 0
2200 - Bankstown
Recruitment postcode(s) [2] 0 0
2747 - Kingswood
Recruitment postcode(s) [3] 0 0
4558 - Maroochydore
Recruitment postcode(s) [4] 0 0
4740 - North Mackay
Recruitment postcode(s) [5] 0 0
3084 - Heidelberg
Recruitment postcode(s) [6] 0 0
3050 - Parkville
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
California
Country [4] 0 0
United States of America
State/province [4] 0 0
Colorado
Country [5] 0 0
United States of America
State/province [5] 0 0
Florida
Country [6] 0 0
United States of America
State/province [6] 0 0
Georgia
Country [7] 0 0
United States of America
State/province [7] 0 0
Illinois
Country [8] 0 0
United States of America
State/province [8] 0 0
Louisiana
Country [9] 0 0
United States of America
State/province [9] 0 0
Maryland
Country [10] 0 0
United States of America
State/province [10] 0 0
Michigan
Country [11] 0 0
United States of America
State/province [11] 0 0
Mississippi
Country [12] 0 0
United States of America
State/province [12] 0 0
Nevada
Country [13] 0 0
United States of America
State/province [13] 0 0
North Carolina
Country [14] 0 0
United States of America
State/province [14] 0 0
Ohio
Country [15] 0 0
United States of America
State/province [15] 0 0
Oklahoma
Country [16] 0 0
United States of America
State/province [16] 0 0
Pennsylvania
Country [17] 0 0
United States of America
State/province [17] 0 0
Tennessee
Country [18] 0 0
United States of America
State/province [18] 0 0
Texas
Country [19] 0 0
United States of America
State/province [19] 0 0
Virginia
Country [20] 0 0
United States of America
State/province [20] 0 0
Washington
Country [21] 0 0
United States of America
State/province [21] 0 0
West Virginia
Country [22] 0 0
United States of America
State/province [22] 0 0
Wisconsin
Country [23] 0 0
Argentina
State/province [23] 0 0
Buenos Aires
Country [24] 0 0
Argentina
State/province [24] 0 0
Tucuman
Country [25] 0 0
Austria
State/province [25] 0 0
Linz
Country [26] 0 0
Austria
State/province [26] 0 0
Wien
Country [27] 0 0
Belarus
State/province [27] 0 0
Gomel
Country [28] 0 0
Belarus
State/province [28] 0 0
Grodno
Country [29] 0 0
Belarus
State/province [29] 0 0
Minsk
Country [30] 0 0
Belarus
State/province [30] 0 0
Vitebsk
Country [31] 0 0
Belgium
State/province [31] 0 0
Gent
Country [32] 0 0
Belgium
State/province [32] 0 0
Merksem
Country [33] 0 0
Belgium
State/province [33] 0 0
Roeselare
Country [34] 0 0
Bulgaria
State/province [34] 0 0
Pleven
Country [35] 0 0
Bulgaria
State/province [35] 0 0
Ruse
Country [36] 0 0
Bulgaria
State/province [36] 0 0
Sliven
Country [37] 0 0
Bulgaria
State/province [37] 0 0
Sofia
Country [38] 0 0
Bulgaria
State/province [38] 0 0
Stara Zagora
Country [39] 0 0
Canada
State/province [39] 0 0
Ontario
Country [40] 0 0
Chile
State/province [40] 0 0
Santiago
Country [41] 0 0
Chile
State/province [41] 0 0
Talca
Country [42] 0 0
Chile
State/province [42] 0 0
Valdivia
Country [43] 0 0
Croatia
State/province [43] 0 0
Koprivnica
Country [44] 0 0
Croatia
State/province [44] 0 0
Osijek
Country [45] 0 0
Croatia
State/province [45] 0 0
Zadar
Country [46] 0 0
Croatia
State/province [46] 0 0
Zagreb
Country [47] 0 0
Czechia
State/province [47] 0 0
Brno
Country [48] 0 0
Czechia
State/province [48] 0 0
Hradec Kralove
Country [49] 0 0
Czechia
State/province [49] 0 0
Klatovy
Country [50] 0 0
Czechia
State/province [50] 0 0
Olomouc
Country [51] 0 0
Czechia
State/province [51] 0 0
Ostrava-Poruba
Country [52] 0 0
Czechia
State/province [52] 0 0
Praha
Country [53] 0 0
Czechia
State/province [53] 0 0
Slany
Country [54] 0 0
Denmark
State/province [54] 0 0
Nordjylland
Country [55] 0 0
Denmark
State/province [55] 0 0
Herlev
Country [56] 0 0
Estonia
State/province [56] 0 0
Tallinn
Country [57] 0 0
France
State/province [57] 0 0
Alpes Maritimes
Country [58] 0 0
France
State/province [58] 0 0
Herault
Country [59] 0 0
France
State/province [59] 0 0
Loire Atlantique
Country [60] 0 0
France
State/province [60] 0 0
Grenoble
Country [61] 0 0
France
State/province [61] 0 0
Vandoeuvre-lès-Nancy
Country [62] 0 0
Georgia
State/province [62] 0 0
Tbilisi
Country [63] 0 0
Germany
State/province [63] 0 0
Nordrhein Westfalen
Country [64] 0 0
Germany
State/province [64] 0 0
Rheinland Pfalz
Country [65] 0 0
Germany
State/province [65] 0 0
Schleswig Holstein
Country [66] 0 0
Germany
State/province [66] 0 0
Berlin
Country [67] 0 0
Germany
State/province [67] 0 0
Düsseldorf
Country [68] 0 0
Germany
State/province [68] 0 0
Neuss
Country [69] 0 0
Germany
State/province [69] 0 0
Schwerin
Country [70] 0 0
Hungary
State/province [70] 0 0
Balatonfured
Country [71] 0 0
Hungary
State/province [71] 0 0
Bekescsaba
Country [72] 0 0
Hungary
State/province [72] 0 0
Budapest
Country [73] 0 0
Hungary
State/province [73] 0 0
Gyongyos
Country [74] 0 0
Hungary
State/province [74] 0 0
Szeged
Country [75] 0 0
Hungary
State/province [75] 0 0
Szekesfehervar
Country [76] 0 0
Hungary
State/province [76] 0 0
Szekszard
Country [77] 0 0
Hungary
State/province [77] 0 0
Tatabanya
Country [78] 0 0
India
State/province [78] 0 0
Andhra Pradesh
Country [79] 0 0
India
State/province [79] 0 0
Gujarat
Country [80] 0 0
India
State/province [80] 0 0
Haryana
Country [81] 0 0
India
State/province [81] 0 0
Kerala
Country [82] 0 0
India
State/province [82] 0 0
Maharashtra
Country [83] 0 0
India
State/province [83] 0 0
Rajasthan
Country [84] 0 0
India
State/province [84] 0 0
Uttar Pradesh
Country [85] 0 0
Israel
State/province [85] 0 0
Afula
Country [86] 0 0
Israel
State/province [86] 0 0
Haifa
Country [87] 0 0
Israel
State/province [87] 0 0
Holon
Country [88] 0 0
Israel
State/province [88] 0 0
Jerusalem
Country [89] 0 0
Israel
State/province [89] 0 0
Nahariya
Country [90] 0 0
Israel
State/province [90] 0 0
Petach Tikva
Country [91] 0 0
Israel
State/province [91] 0 0
Ramat Gan
Country [92] 0 0
Israel
State/province [92] 0 0
Rehovot
Country [93] 0 0
Italy
State/province [93] 0 0
Bari
Country [94] 0 0
Italy
State/province [94] 0 0
Milano
Country [95] 0 0
Italy
State/province [95] 0 0
Verona
Country [96] 0 0
Italy
State/province [96] 0 0
Brescia
Country [97] 0 0
Italy
State/province [97] 0 0
Catania
Country [98] 0 0
Italy
State/province [98] 0 0
Catanzaro
Country [99] 0 0
Italy
State/province [99] 0 0
Modena
Country [100] 0 0
Italy
State/province [100] 0 0
Roma
Country [101] 0 0
Italy
State/province [101] 0 0
Vicenza
Country [102] 0 0
Korea, Republic of
State/province [102] 0 0
Daegu
Country [103] 0 0
Korea, Republic of
State/province [103] 0 0
Gangwon-do
Country [104] 0 0
Korea, Republic of
State/province [104] 0 0
Gyeonggi-do
Country [105] 0 0
Korea, Republic of
State/province [105] 0 0
Seodaemun-gu
Country [106] 0 0
Korea, Republic of
State/province [106] 0 0
Busan
Country [107] 0 0
Latvia
State/province [107] 0 0
Riga
Country [108] 0 0
Lebanon
State/province [108] 0 0
Beirut
Country [109] 0 0
Lithuania
State/province [109] 0 0
Kaunas
Country [110] 0 0
Lithuania
State/province [110] 0 0
Klaipeda
Country [111] 0 0
Lithuania
State/province [111] 0 0
Panevezys
Country [112] 0 0
Lithuania
State/province [112] 0 0
Vilnius
Country [113] 0 0
Mexico
State/province [113] 0 0
Jalisco
Country [114] 0 0
Mexico
State/province [114] 0 0
Nuevo León
Country [115] 0 0
Mexico
State/province [115] 0 0
Chihuahua
Country [116] 0 0
Mexico
State/province [116] 0 0
Veracruz
Country [117] 0 0
Moldova, Republic of
State/province [117] 0 0
Chisinau
Country [118] 0 0
Netherlands
State/province [118] 0 0
Geleen
Country [119] 0 0
Netherlands
State/province [119] 0 0
Tilburg
Country [120] 0 0
Poland
State/province [120] 0 0
Bedzin
Country [121] 0 0
Poland
State/province [121] 0 0
Bialystok
Country [122] 0 0
Poland
State/province [122] 0 0
Czestochowa
Country [123] 0 0
Poland
State/province [123] 0 0
Jelenia Gora
Country [124] 0 0
Poland
State/province [124] 0 0
Kraków
Country [125] 0 0
Poland
State/province [125] 0 0
Lodz
Country [126] 0 0
Poland
State/province [126] 0 0
Nowy Targ
Country [127] 0 0
Poland
State/province [127] 0 0
Oswiecim
Country [128] 0 0
Poland
State/province [128] 0 0
Poznan
Country [129] 0 0
Poland
State/province [129] 0 0
Rzeszow
Country [130] 0 0
Poland
State/province [130] 0 0
Sopot
Country [131] 0 0
Poland
State/province [131] 0 0
Szczecin
Country [132] 0 0
Poland
State/province [132] 0 0
Warsaw
Country [133] 0 0
Poland
State/province [133] 0 0
Wroclaw
Country [134] 0 0
Portugal
State/province [134] 0 0
Braga
Country [135] 0 0
Portugal
State/province [135] 0 0
Coimbra
Country [136] 0 0
Portugal
State/province [136] 0 0
Porto
Country [137] 0 0
Portugal
State/province [137] 0 0
Vila Nova de Gaia
Country [138] 0 0
Romania
State/province [138] 0 0
Bucharest
Country [139] 0 0
Romania
State/province [139] 0 0
Bucuresti
Country [140] 0 0
Romania
State/province [140] 0 0
Cluj-Napoca
Country [141] 0 0
Romania
State/province [141] 0 0
Craiova
Country [142] 0 0
Romania
State/province [142] 0 0
Oradea
Country [143] 0 0
Russian Federation
State/province [143] 0 0
Barnaul
Country [144] 0 0
Russian Federation
State/province [144] 0 0
Irkutsk
Country [145] 0 0
Russian Federation
State/province [145] 0 0
Kazan
Country [146] 0 0
Russian Federation
State/province [146] 0 0
Kemerovo
Country [147] 0 0
Russian Federation
State/province [147] 0 0
Nizhniy Novgorod
Country [148] 0 0
Russian Federation
State/province [148] 0 0
Novosibirsk
Country [149] 0 0
Russian Federation
State/province [149] 0 0
Omsk
Country [150] 0 0
Russian Federation
State/province [150] 0 0
Penza
Country [151] 0 0
Russian Federation
State/province [151] 0 0
Saint Petersburg
Country [152] 0 0
Russian Federation
State/province [152] 0 0
Samara
Country [153] 0 0
Russian Federation
State/province [153] 0 0
Sestroretsk
Country [154] 0 0
Russian Federation
State/province [154] 0 0
Smolensk
Country [155] 0 0
Russian Federation
State/province [155] 0 0
Stavropol
Country [156] 0 0
Serbia
State/province [156] 0 0
Belgrade
Country [157] 0 0
Serbia
State/province [157] 0 0
Kragujevac
Country [158] 0 0
Serbia
State/province [158] 0 0
Sremska Mitrovica
Country [159] 0 0
Slovakia
State/province [159] 0 0
Presov
Country [160] 0 0
Slovakia
State/province [160] 0 0
Banska Bystrica
Country [161] 0 0
Slovakia
State/province [161] 0 0
Bardejov
Country [162] 0 0
Slovakia
State/province [162] 0 0
Nitra
Country [163] 0 0
Slovakia
State/province [163] 0 0
Nove Zamky
Country [164] 0 0
Slovakia
State/province [164] 0 0
Sahy
Country [165] 0 0
South Africa
State/province [165] 0 0
Centurion
Country [166] 0 0
South Africa
State/province [166] 0 0
Gauteng
Country [167] 0 0
South Africa
State/province [167] 0 0
Western Cape
Country [168] 0 0
Spain
State/province [168] 0 0
Madrid
Country [169] 0 0
Taiwan
State/province [169] 0 0
Taichung
Country [170] 0 0
Taiwan
State/province [170] 0 0
Taipei
Country [171] 0 0
Thailand
State/province [171] 0 0
Bangkok
Country [172] 0 0
Thailand
State/province [172] 0 0
Chiang Mai
Country [173] 0 0
Turkey
State/province [173] 0 0
Yenimahalle / Ankara
Country [174] 0 0
Turkey
State/province [174] 0 0
Ankara
Country [175] 0 0
Turkey
State/province [175] 0 0
Antalya
Country [176] 0 0
Turkey
State/province [176] 0 0
Kocaeli
Country [177] 0 0
Ukraine
State/province [177] 0 0
Dnipro
Country [178] 0 0
Ukraine
State/province [178] 0 0
Ivano-Frankivsk
Country [179] 0 0
Ukraine
State/province [179] 0 0
Kharkiv
Country [180] 0 0
Ukraine
State/province [180] 0 0
Kherson
Country [181] 0 0
Ukraine
State/province [181] 0 0
Kremenchuk
Country [182] 0 0
Ukraine
State/province [182] 0 0
Kyiv
Country [183] 0 0
Ukraine
State/province [183] 0 0
Lviv
Country [184] 0 0
Ukraine
State/province [184] 0 0
Odesa
Country [185] 0 0
Ukraine
State/province [185] 0 0
Uzhgorod
Country [186] 0 0
Ukraine
State/province [186] 0 0
Vinnytsia
Country [187] 0 0
Ukraine
State/province [187] 0 0
Zaporizhzhia
Country [188] 0 0
United Kingdom
State/province [188] 0 0
Greater London
Country [189] 0 0
United Kingdom
State/province [189] 0 0
Norfolk
Country [190] 0 0
United Kingdom
State/province [190] 0 0
Somerset
Country [191] 0 0
United Kingdom
State/province [191] 0 0
Belfast
Country [192] 0 0
United Kingdom
State/province [192] 0 0
Hemel Hempstead

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Arena Pharmaceuticals
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of this study is to determine whether oral etrasimod is a safe and effective
treatment for moderately to severely active ulcerative colitis.
Trial website
https://clinicaltrials.gov/ct2/show/NCT03945188
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Arena CT.gov Administrator
Address 0 0
Arena Pharmaceuticals
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results are available at https://clinicaltrials.gov/ct2/show/NCT03945188